APA (7th ed.) Citation

Ge, Y., Liu, X., Xu, Y., Su, Y., Li, Y., & Wang, L. Combined systemic immune-inflammatory index and prognostic nutritional index predicts the efficacy and prognosis of ES-SCLC patients receiving PD-L1 inhibitors combined with first-line chemotherapy. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Ge, Yi, Xiaoyu Liu, Yishi Xu, Yanwei Su, Yixin Li, and Liping Wang. Combined Systemic Immune-inflammatory Index and Prognostic Nutritional Index Predicts the Efficacy and Prognosis of ES-SCLC Patients Receiving PD-L1 Inhibitors Combined with First-line Chemotherapy. Frontiers Media S.A.

MLA (9th ed.) Citation

Ge, Yi, et al. Combined Systemic Immune-inflammatory Index and Prognostic Nutritional Index Predicts the Efficacy and Prognosis of ES-SCLC Patients Receiving PD-L1 Inhibitors Combined with First-line Chemotherapy. Frontiers Media S.A.